347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD)

Journal article

Peer reviewed

Michael Paidas, Elizabeth Triche, Andra James, Trina Ballard and Simon Lowry

American journal of obstetrics and gynecology, Vol.208(1), pp.S154-S154

2013-01

Metrics

1 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD)
Creators: Michael Paidas - Yale University
Elizabeth Triche - Brown University
Andra James - National Institutes of Health
Trina Ballard - GTC Biotherapeutics, Inc., GTC Biotherapeutics, Inc., Framingham, MA
Simon Lowry - GTC Biotherapeutics, Inc., GTC Biotherapeutics, Inc., Framingham, MA
Publication Details: American journal of obstetrics and gynecology, Vol.208(1), pp.S154-S154
Publisher: Elsevier Inc
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Obstetrics & Gynecology
Language: English
Resource Type: Journal article
Record Identifier: 991031713639002976